Skip to main content
. 2004 Jul;53(7):952–957. doi: 10.1136/gut.2003.033563

Figure 3.

Figure 3

 Number of days with diarrhoea (NDD) after treatment of rotavirus infected mice with the 5-HT3 receptor antagonist granisetron, the 5-HT4 receptor antagonist RS 39604, or a combination of a vasoactive intestinal peptide receptor antagonist (VIPa) (1.5 mg/kg) and granisetron (2 mg/kg) (Granis+VIP). Non-treated rotavirus infected mice served as controls. Values in columns indicate the number of mice. Values are means (SEM). *p<0.05, **p<0.01 compared with controls (Student’s t test).